CAR-T

First Indigenous CD19 CAR-T Therapy Approved for Market in China, National CAR-T Research Enters a Boom Period!

On November 8, 2023, we have received another major piece of good news! According to the official website of the National Medical Products Administration (NMPA) of China, the new drug application (NDA) for Inaticabtagene Autoleucel Injection (CNCT19 Cell Injection), a CAR-T therapy product developed by Hegen Biotech, has been officially approved for market. This therapy Read More

November 22nd,2023 CAR-T

Completely relieved for up to 8 years! China’s innovative CAR-T therapy brings the dawn of “cure” for advanced cancer

Two long-term disease-free survival cases of advanced liver cancer treated with CAR-GPC3 T cell therapy developed by Chinese scientists were published in the internationally renowned immunology journal Cancer Communications. One of the patients has achieved complete remission of the tumor for 8 years, which is a major breakthrough in China’s anti-cancer research. This therapy is Read More

November 22nd,2023 CAR-T

Sarcoma: 5 Things to Know About This

Dr Richard Quek, Senior Consultant, Medical Oncology, explains 5 things you need to know about sarcoma, one of the rarest forms of cancer. Sarcoma is a rare form of cancer that affects the bones, connective tissues of the body, and areas such as blood vessels, muscle, nerves and fat. It is a complex and diverse disease, with Read More

November 9th,2023 CAR-T

Understanding the Types of Leukaemia

Leukaemia means cancer of blood cells. It can be classified into two main categihgffddjories: AcuteppppmmpppjjjjLeukaemias and other types of Leukaemias. In this issue of HealthNews, we break down the types of Leukaemia and how advances in treatment are improving the survival outlook for patients with the disease. Leukaemia is a type of blood cancer that Read More

November 9th,2023 CAR-T

Hodgkin vs Non-Hodgkin Lymphoma:

They may sound similar, but Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) are two distinct types of lymphoma, each with unique disease characteristics. In this issue of HealthNews, we look at some of the key differences between them. Lymphoma is a type of blood cancer that begins in the lymphatic system—a network of vessels, nodes, and ducts throughout the Read More

November 9th,2023 CAR-T

CAR T-cell Therapy: The Past, Present & Future

Chimeric Antigen Receptor (CAR) T-cell Therapy has been hailed as the next frontier of oncology, as it is an innovative and revolutionary approach to treating cancers. Here is a look at how the treatment has evolved from the past into the present, and towards the future. As its name suggests, CAR T-cell Therapy is a type Read More

November 9th,2023 CAR-T

How CAR T-Cell Therapy is Changing the Landscape of Cancer Care

Chimeric Antigen Receptor (CAR) T-cell Therapy is making revolutionary breakthroughs in the field of Haematology by engineering immune cells to treat cancer. For decades, the mainstay of cancer treatment has been surgery, chemotherapy and radiation therapy. While these treatment modalities continue to be the main pillars of cancer care, the emergence of targeted therapies, immune-based therapies, and cell therapies most notably CAR T-cell Therapy Read More

November 9th,2023 CAR-T

Understanding the 5 Main Types of Head & Neck Cancers

In this issue of HealthNews, medical oncologist Dr Lim Hong Liang tells us about the main types of head and neck cancers, the signs and symptoms to look out for, as well as the treatment available for patients at different disease stages. Head and neck cancers are a group of cancers that begin in the mouth, throat, nose, Read More

November 9th,2023 CAR-T

Stomach Cancer: The Silent Killer

Stomach cancer is the seventh most common cancer in Singaporean men, and the ninth most common cancer in Singaporean women1. Symptoms do not show until later stages, making this disease ‘a silent killer’ that takes about 700,000 lives globally every year2. Dr Foo Kian Fong shares more. The stomach is an organ in the gastrointestinal (GI) tract Read More

November 9th,2023 CAR-T

5 Common Questions About Cancer Pain, Answered

In this issue of HealthNews, Dr Kok Jaan Yang, Senior Consultant, Palliative Medicine, answers some common questions about cancer pain. What causes cancer pain? Cancer pain is generally caused by cancer invading and damaging the surrounding tissues or organs of the body. However, not all pain experienced by advanced cancer patients is directly caused by cancer. An estimated Read More

November 2nd,2023 CAR-T